Food supplements: a better way to utilise the body’s microbiome? Stuart J. Ashman, CEO, and Dr Catherine O’Neill, CSO, SkinBioTherapeutics, investigate
AI-native modelling and GPU-driven simulation are transforming drug discovery workflows and reshaping the balance between pharma and biotech
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.